Scientists found that aggressive lung cancer cells create their own electrical network, helping them spread. This unique ...

Economic Toxicity, Lung Cancer, Multi-Center Trial, Correlation Analysis Share and Cite: Mao, R.M. and Peng, L.Y. (2025) Multi-Center Investigation on the Level of Economic Toxicity in Patients with ...

Jennifer Marie Suga, MD, shares the lung cancer research she’s eager to explore as new data emerges. Jennifer Marie Suga, MD, ...

SAVANNAH Phase II trial demonstrated high and durable response rates with savolitinib plus TAGRISSO® in MET-high lung cancer, representing a ...

Extensive stage SCLC. In this stage, cancer has spread from the lung to other parts of the body. About 2 in 3 people with SCLC have extensive disease when they first get diagnosed. Treatment can ...

As an expert explained in an interview with CURE, we may be in the midst of a “new era” for small cell lung cancer research.

Chen, F. (2025) Advances in the Application of Deep Learning in Prognostic Models for Non-Small Cell Lung Cancer. Health, 17, ...

Lung cancer develops and progresses quickly. This is why it is often diagnosed at an advanced, incurable stage. Screening for ... Without treatment, survival is about 2 to 4 months.

In the continuing evolution of personalized medicine, a new Yale study has found evidence to support the value of a tool that ...

EGFR inhibitor Tagrisso (osimertinib) has now become the first drug to show an improvement in overall survival (OS) in patients with early-stage, EGFR-mutated non-small cell lung cancer (NSCLC ...

with chemotherapy in stage 2 to 3b non-small cell lung cancer (NSCLC) patients who can be treated with surgery, followed by Keytruda and V940 given as adjuvant therapy. Specifically, it will enrol ...